Manuela Silginer

1.6k total citations
31 papers, 1.0k citations indexed

About

Manuela Silginer is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Manuela Silginer has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Manuela Silginer's work include Glioma Diagnosis and Treatment (14 papers), Immunotherapy and Immune Responses (5 papers) and interferon and immune responses (4 papers). Manuela Silginer is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Immunotherapy and Immune Responses (5 papers) and interferon and immune responses (4 papers). Manuela Silginer collaborates with scholars based in Switzerland, Germany and United States. Manuela Silginer's co-authors include Michael Weller, Patrick Roth, Caroline Happold, Guido Reifenberger, Hannah Schneider, Tobias Weiß, Roger Stupp, Ana‐Maria Florea, Wolfgang Wick and Kathy Hasenbach and has published in prestigious journals such as Journal of Clinical Oncology, Brain and Cancer Research.

In The Last Decade

Manuela Silginer

30 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuela Silginer Switzerland 16 415 361 344 289 174 31 1.0k
Susobhan Sarkar Canada 19 409 1.0× 429 1.2× 381 1.1× 564 2.0× 255 1.5× 29 1.3k
James S. Hale United States 18 663 1.6× 309 0.9× 411 1.2× 251 0.9× 362 2.1× 30 1.2k
George Ansstas United States 17 337 0.8× 428 1.2× 471 1.4× 277 1.0× 181 1.0× 75 1.1k
Thomas Daubon France 21 696 1.7× 238 0.7× 278 0.8× 172 0.6× 268 1.5× 54 1.3k
Tali Voloshin Israel 19 490 1.2× 495 1.4× 404 1.2× 207 0.7× 199 1.1× 79 1.4k
Mihaela Lorger United Kingdom 17 492 1.2× 275 0.8× 523 1.5× 207 0.7× 144 0.8× 29 1.2k
Rikke Hedegaard Dahlrot Denmark 18 443 1.1× 544 1.5× 266 0.8× 215 0.7× 319 1.8× 60 1.1k
Saket Jain United States 18 455 1.1× 201 0.6× 256 0.7× 195 0.7× 271 1.6× 30 925
Shannon Donnola United States 7 372 0.9× 317 0.9× 292 0.8× 118 0.4× 274 1.6× 10 849
Jin‐Kyoung Shim South Korea 19 411 1.0× 419 1.2× 291 0.8× 124 0.4× 313 1.8× 52 924

Countries citing papers authored by Manuela Silginer

Since Specialization
Citations

This map shows the geographic impact of Manuela Silginer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Silginer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Silginer more than expected).

Fields of papers citing papers by Manuela Silginer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Silginer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Silginer. The network helps show where Manuela Silginer may publish in the future.

Co-authorship network of co-authors of Manuela Silginer

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Silginer. A scholar is included among the top collaborators of Manuela Silginer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Silginer. Manuela Silginer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peipp, Matthias, Renier Myburgh, Manuela Silginer, et al.. (2023). Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma. Neuro-Oncology. 25(11). 2001–2014. 9 indexed citations
2.
Silginer, Manuela, Eleanna Papa, Emese Szabó, et al.. (2023). Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition. Acta Neuropathologica Communications. 11(1). 41–41. 3 indexed citations
3.
Silginer, Manuela, et al.. (2022). CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner. Cell Death Discovery. 8(1). 341–341. 8 indexed citations
4.
Silginer, Manuela, et al.. (2022). Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models. Translational Oncology. 28. 101607–101607. 3 indexed citations
5.
Silginer, Manuela, et al.. (2022). CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models. Journal of Neuro-Oncology. 160(2). 299–310. 3 indexed citations
6.
Silginer, Manuela, et al.. (2020). Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation. Molecular Cancer Therapeutics. 19(6). 1328–1339. 23 indexed citations
7.
Weiß, Tobias, Emanuele Puca, Manuela Silginer, et al.. (2020). Immunocytokines are a promising immunotherapeutic approach against glioblastoma. Science Translational Medicine. 12(564). 94 indexed citations
8.
Wirsching, Hans‐Georg, Manuela Silginer, Will Macnair, et al.. (2020). Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma. Molecular Therapy — Oncolytics. 20. 166–174. 5 indexed citations
9.
Silginer, Manuela, Daniel Picard, Hannah Schneider, et al.. (2020). Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity. Neuro-Oncology Advances. 2(1). vdaa043–vdaa043. 5 indexed citations
10.
Silginer, Manuela, Michael Weller, Hannah Schneider, et al.. (2019). Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas. Clinical Cancer Research. 25(23). 7189–7201. 39 indexed citations
11.
Werner, Beat, Davide Brambilla, Paola Luciani, et al.. (2018). Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes. Journal of Controlled Release. 295. 130–139. 78 indexed citations
12.
Neidert, Marian C., Daniel J. Kowalewski, Manuela Silginer, et al.. (2018). The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy. Acta Neuropathologica. 135(6). 923–938. 29 indexed citations
13.
Happold, Caroline, Manuela Silginer, Tobias Weiß, et al.. (2018). Transcriptional control of O6‐methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma. Journal of Neurochemistry. 144(6). 780–790. 25 indexed citations
14.
Weiß, Tobias, Hannah Schneider, Manuela Silginer, et al.. (2017). NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma. Clinical Cancer Research. 24(4). 882–895. 90 indexed citations
15.
Silginer, Manuela, et al.. (2017). Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma. Neuro-Oncology. 19(10). 1338–1349. 48 indexed citations
16.
Silginer, Manuela, et al.. (2017). Biological activity of tumor-treating fields in preclinical glioma models. Cell Death and Disease. 8(4). e2753–e2753. 89 indexed citations
17.
Silginer, Manuela, Isabel Burghardt, Dorothee Gramatzki, et al.. (2015). The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway. Oncogene. 35(25). 3260–3271. 51 indexed citations
18.
Happold, Caroline, Patrick Roth, Manuela Silginer, et al.. (2014). Interferon-β Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells. Molecular Cancer Therapeutics. 13(4). 948–961. 43 indexed citations
19.
Roth, Patrick, Manuela Silginer, Simon L. Goodman, et al.. (2013). Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain. 136(2). 564–576. 91 indexed citations
20.
Happold, Caroline, Patrick Roth, Wolfgang Wick, et al.. (2012). Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells. Journal of Neurochemistry. 122(2). 444–455. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susobhan Sarkar Breakdown of academic impact, for papers by James S. Hale Breakdown of academic impact, for papers by George Ansstas Breakdown of academic impact, for papers by Thomas Daubon Breakdown of academic impact, for papers by Tali Voloshin Breakdown of academic impact, for papers by Mihaela Lorger Breakdown of academic impact, for papers by Rikke Hedegaard Dahlrot Breakdown of academic impact, for papers by Saket Jain Breakdown of academic impact, for papers by Shannon Donnola Breakdown of academic impact, for papers by Jin‐Kyoung Shim
Rankless by CCL
2026